PPT-Balloon-Expandable TAVR in Inoperable Patients With Severe

The PARTNER Trial Cohort B 2Year Results The information in this slide deck is intended for educational purposes only and should be read and used in its entirety Background 3 September 22 2010 on . The PARTNER Trial Cohort B 2-Year Results. The information in this slide deck is intended for educational purposes only, and should be read and used in its entirety.. Background. 3. September 22, 2010 on . Surgery . vs. SBRT . vs. RFA. November 16, 2012. Ramesh Rengan MD PhD. Chief, Thoracic Service. Assistant Director of Clinical Operations. Department of Radiation Oncology. DISCLOSURES. Speaker Honoraria. Important Considerations . as TAVR Moves to . Lower-Risk Patients. Benjamin Z Galper MD MPH. Brigham & Women’s Hospital Boston MA. Consequences of Stroke. Mortality. – TAVR patients suffering a VARC-2 disabling stroke have significantly higher mortality rates compared to patients without stroke. 1-year mortality of 67% vs. 12% and 2-year mortality of 83% vs. 20%.. Professor & Vice-Chairman Department of Neurosurgery. Director Neurosurgical Stroke Service, . Kaleida. Health. Chief Medical Officer, Jacobs Institute. Presenting endorsed statement from. American Association of Neurological Surgeons (AANS). Overview of Anticoagulation in . Interventional Cardiology. Rivaroxaban in Patients With Recent ACS:. ATLAS ACS 2-TIMI 51. Apixaban After ACS: APPRAISE-2. How Do You Treat Complex Patients?. ACC/AHA Guidelines. Stanton J Rowe. CEO. NXT Biomedical. I, Stanton Rowe, DO have a financial interest/arrangement . or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.. ”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interventional cardiologist. Director, Cardiac Cath Lab, . Crozer. Chester Medical Center,. Upland, PA. . Disclosure. Consultant and Proctor – Medtronic. GatewayTMPTA Balloon CatheterInstructions for UseHumanitarian Device: The Wingspan Stent System with Gateway PTA Balloon Catheter is Authorizedby Federal law for use in improving cerebral artery lumen 93 Postpartum Haemorrhage: Case Series from a Tertiary Care Hospital Sudha R 1 , Anjali R 2 ORIGINAL RESEARCH Introduction: Uterine balloon tamponade technology is nowadays popularly used to control 1 Disclosure Statement of Financial InterestsWithin the past 12 months, I have had a financial interest/arrangement or affiliation with the organization(s) listed below.Financial RelationshipCompanyRe Endometrial Cancer Adannia Ufondu , MS - 4 Resident Mentor: Bailey Nelson, PGY - 4 Faculty Advisor: Teresa Meier, MD University of Cincinnati, Department of Radiation Oncology Cincinnati, Ohio Septe A Heart Team Perspective. Interventional cardiology: . Megan Coylewright, MD MPH FSCAI. Dartmouth-Hitchcock Heart and Vascular Center. Cardiac surgery: . Melissa Levack, MD. Vanderbilt University Medical Center. Brandon M. Jones, MD. Interventional Cardiology. Providence Heart and Vascular Institute. Portland, Oregon. Disclosures. None. Case:. 60 y/o M with h/o HTN, HLD, and Type 2 Diabetes.. Right heel ulcer has now been present for ~1 year.. Evolut. Low Risk Bicuspid Study. Basel Ramlawi, MD, FACC. Valley Health System, Winchester, Virginia. For the . Evolut. Low Risk Bicuspid Investigators. Disclosure Statement of Financial Interests.